BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sasaki R, Kanda T, Nakamoto S, Haga Y, Nakamura M, Yasui S, Jiang X, Wu S, Arai M, Yokosuka O. Natural interferon-beta treatment for patients with chronic hepatitis C in Japan. World J Hepatol 2015; 7(8): 1125-1132 [PMID: 26052401 DOI: 10.4254/wjh.v7.i8.1125]
URL: https://www.wjgnet.com/1007-9327/full/v7/i8/1125.htm
Number Citing Articles
1
Reina Sasaki, Tatsuo Kanda, Shin Yasui, Yuki Haga, Masato Nakamura, Mutsumi Yamato, Shuang Wu, Shingo Nakamoto, Makoto Arai, Shigeru Mikami, Hideaki Miyauchi, Hisahiro Matsubara, Osamu Yokosuka. Successful Eradication of Hepatitis C Virus by Interferon-Free Regimens in Two Patients with Advanced Liver Fibrosis following Kidney TransplantationCase Reports in Gastroenterology 2016; 10(2): 248 doi: 10.1159/000445374
2
Alexey S. Kazakov, Alexander D. Sofin, Nadezhda V. Avkhacheva, Alexander I. Denesyuk, Evgenia I. Deryusheva, Victoria A. Rastrygina, Andrey S. Sokolov, Maria E. Permyakova, Ekaterina A. Litus, Vladimir N. Uversky, Eugene A. Permyakov, Sergei E. Permyakov. Interferon Beta Activity Is Modulated via Binding of Specific S100 ProteinsInternational Journal of Molecular Sciences 2020; 21(24): 9473 doi: 10.3390/ijms21249473
3
Thomas Ward, Samantha Webster, Sari Mishina, Phil McEwan, Gail Wygant, Feng Wang. Assessing the Budget Impact and Economic Outcomes of the Introduction of Daclatasvir + Asunaprevir and Sofosbuvir/Ledipasvir for the Treatment of Chronic Hepatitis C Virus Infection in JapanValue in Health Regional Issues 2017; 12: 1 doi: 10.1016/j.vhri.2016.10.002
4
Tatsuo Kanda, Kazushige Nirei, Naoki Matsumoto, Teruhisa Higuchi, Hitomi Nakamura, Hiroaki Yamagami, Shunichi Matsuoka, Mitsuhiko Moriyama. Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1bWorld Journal of Gastroenterology 2017; 23(46): 8120-8127 doi: 10.3748/wjg.v23.i46.8120
5
Nicholas A. Hummell, Alexey V. Revtovich, Natalia V. Kirienko, Paul Dunman. Novel Immune Modulators Enhance Caenorhabditis elegans Resistance to Multiple Pathogens mSphere 2021; 6(1) doi: 10.1128/mSphere.00950-20
6
Kamil Grubczak, Anna Grzeszczuk, Monika Groth, Anna Hryniewicz, Anna Kretowska-Grunwald, Robert Flisiak, Marcin Moniuszko. Effects of Pegylated Interferon Alpha and Ribavirin (pegIFN-α/RBV) Therapeutic Approach on Regulatory T Cells in HCV-Monoinfected and HCV/HIV-Coinfected PatientsViruses 2021; 13(8): 1448 doi: 10.3390/v13081448
7
Saleh A. Alqahtani, Mark S. Sulkowski. HCV: The Journey from Discovery to a CureTopics in Medicinal Chemistry 2019; 31: 97 doi: 10.1007/7355_2018_59
8
Reina Sasaki-Tanaka, Toshikatsu Shibata, Hiroaki Okamoto, Mitsuhiko Moriyama, Tatsuo Kanda. Favipiravir Inhibits Hepatitis A Virus Infection in Human HepatocytesInternational Journal of Molecular Sciences 2022; 23(5): 2631 doi: 10.3390/ijms23052631
9
Noha G. Bader El Din, Sally Farouk. Exploring the Impact of Different Inflammatory Cytokines on Hepatitis C Virus InfectionJournal of Interferon & Cytokine Research 2024; 44(6): 233 doi: 10.1089/jir.2024.0003
10
Reina Sasaki, Tatsuo Kanda, Naoya Kato, Osamu Yokosuka, Mitsuhiko Moriyama. Hepatitis C virus-associated hepatocellular carcinoma after sustained virologic responseWorld Journal of Hepatology 2018; 10(12): 898-906 doi: 10.4254/wjh.v10.i12.898